Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness
Clinical trial NCT04337359 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04337359
- Sponsor
- Novartis Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.